-
1
-
-
0030586445
-
Clinical and epidemiological features of primary HIV infection
-
Schacker T, Collier AC, Hughes J, Shea T, Corey L. Clinical and epidemiological features of primary HIV infection. Ann Intern Med 1996; 125: 257-64.
-
(1996)
Ann. Intern. Med.
, vol.125
, pp. 257-264
-
-
Schacker, T.1
Collier, A.C.2
Hughes, J.3
Shea, T.4
Corey, L.5
-
2
-
-
0028124949
-
Markers of immune stimulation in the cerebrospinal fluid during HIV infection: A longitudinal study
-
Gisslén M, Chiodi F, Fuchs D, Norkrans G, Svennerholm B, Wachter H, Hagberg L. Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study. Scand J Infect Dis 1994; 26: 523-33.
-
(1994)
Scand. J. Infect. Dis.
, vol.26
, pp. 523-533
-
-
Gisslén, M.1
Chiodi, F.2
Fuchs, D.3
Norkrans, G.4
Svennerholm, B.5
Wachter, H.6
Hagberg, L.7
-
3
-
-
0032485436
-
Cerebrospinal fluid HIV-1 RNA levels: Correlation with HIV encephalitis
-
Cinque P, Vago L, Ceresa D, Mainini F, Terreni MR, Vagani A, et al. Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis. Aids 1998; 12: 389-94.
-
(1998)
Aids
, vol.12
, pp. 389-994
-
-
Cinque, P.1
Vago, L.2
Ceresa, D.3
Mainini, F.4
Terreni, M.R.5
Vagani, A.6
-
4
-
-
0030901509
-
Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage
-
Brew BJ, Pemberton L, Cunningham P, Law MG. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis 1997; 175: 963-6.
-
(1997)
J. Infect. Dis.
, vol.175
, pp. 963-966
-
-
Brew, B.J.1
Pemberton, L.2
Cunningham, P.3
Law, M.G.4
-
5
-
-
17044457875
-
ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results
-
Murphy RL, Brun S, Hicks C, Eron JJ, Gulick R, King M, et al. ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results. Aids 2001; 15: F1-9.
-
(2001)
Aids
, vol.15
-
-
Murphy, R.L.1
Brun, S.2
Hicks, C.3
Eron, J.J.4
Gulick, R.5
King, M.6
-
6
-
-
0031972548
-
HIV-1 RNA detectable with ultrasensitive quantitative polymerase chain reaction in plasma but not in cerebrospinal fluid during combination treatment with zidovudine, lamivudine and indinavir
-
Gisslén M, Norkrans G, Svennerholm B, Hagberg L. HIV-1 RNA detectable with ultrasensitive quantitative polymerase chain reaction in plasma but not in cerebrospinal fluid during combination treatment with zidovudine, lamivudine and indinavir. Aids 1998; 12: 114-6.
-
(1998)
Aids
, vol.12
, pp. 114-116
-
-
Gisslén, M.1
Norkrans, G.2
Svennerholm, B.3
Hagberg, L.4
-
7
-
-
0030791962
-
Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir
-
Pialoux G, Fournier S, Moulignier A, Poveda JD, Clavel F, Dupont B. Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir. Aids 1997; 11: 1302-3.
-
(1997)
Aids
, vol.11
, pp. 1302-1303
-
-
Pialoux, G.1
Fournier, S.2
Moulignier, A.3
Poveda, J.D.4
Clavel, F.5
Dupont, B.6
-
8
-
-
0027122957
-
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
-
RR-17
-
3 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Weekly Rep 1992; 41: RR-17.
-
(1992)
MMWR Morb. Mortal. Weekly Rep.
, vol.41
-
-
-
9
-
-
0023025943
-
Measurement of beta-2-microglobulin in human cerebrospinal fluid by ELISA technique
-
Bjerrum OW, Lage S, Hansen OE. Measurement of beta-2-microglobulin in human cerebrospinal fluid by ELISA technique. Acta Neurol Scand 1986; 74: 177-80.
-
(1986)
Acta Neurol. Scand.
, vol.74
, pp. 177-180
-
-
Bjerrum, O.W.1
Lage, S.2
Hansen, O.E.3
-
10
-
-
0023186976
-
Determination of neopterin in serum and urine
-
Werner E, Bichler A, Daxenbichler G, Fuchs D, Fuith L, Hansen A. Determination of neopterin in serum and urine. Clin Chem 1987; 33: 62-6.
-
(1987)
Clin. Chem.
, vol.33
, pp. 62-66
-
-
Werner, E.1
Bichler, A.2
Daxenbichler, G.3
Fuchs, D.4
Fuith, L.5
Hansen, A.6
-
11
-
-
0031588522
-
Indinavir in cerebrospinal fluid of HIV-1 infected patients
-
Stable L, Martin C, Svensson JO, Sonnerborg A. Indinavir in cerebrospinal fluid of HIV-1 infected patients. Lancet 1997; 350: 1823.
-
(1997)
Lancet
, vol.350
, pp. 1823
-
-
Stable, L.1
Martin, C.2
Svensson, J.O.3
Sonnerborg, A.4
-
12
-
-
0033928524
-
Indinavir population pharmacokinetics in plasma and cerebrospinal fluid
-
The HIV Neurobehavioral Research Center Group
-
Letendre SL, Capparelli EV, Ellis RJ, McCutchan JA. Indinavir population pharmacokinetics in plasma and cerebrospinal fluid. The HIV Neurobehavioral Research Center Group. Antimicrob Agents Chemother 2000; 44: 2173-5.
-
(2000)
Antimicrob. Agents Chemother.
, vol.44
, pp. 2173-2175
-
-
Letendre, S.L.1
Capparelli, E.V.2
Ellis, R.J.3
McCutchan, J.A.4
-
13
-
-
0032560373
-
Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine
-
Foudraine NA, Hoetelmans RM, Lange JM, de Wolf F, van Benthem BH, Maas JJ, et al. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine. Lancet 1998; 351: 1547-51.
-
(1998)
Lancet
, vol.351
, pp. 1547-1551
-
-
Foudraine, N.A.1
Hoetelmans, R.M.2
Lange, J.M.3
de Wolf, F.4
van Benthem, B.H.5
Maas, J.J.6
-
14
-
-
0027732250
-
Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV
-
Burger DM, Kraaijeveld CL, Meenhorst PL, Mulder JW, Koks CH, Bult A, Beijnen JH. Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV Aids 1993; 7: 1581-7.
-
(1993)
Aids
, vol.7
, pp. 1581-1587
-
-
Burger, D.M.1
Kraaijeveld, C.L.2
Meenhorst, P.L.3
Mulder, J.W.4
Koks, C.H.5
Bult, A.6
Beijnen, J.H.7
-
16
-
-
0032585875
-
Pharmacokinetics of [(14)C] abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1 infected adults: A mass balance study
-
McDowell JA, Chittick GE, Ravitch JR, Polk RE, Kerkering TM, Stein DS. Pharmacokinetics of [(14)C] abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1 infected adults: a mass balance study. Antimicrob Agents Chemother 1999; 43: 2855-61.
-
(1999)
Antimicrob. Agents Chemother.
, vol.43
, pp. 2855-2861
-
-
McDowell, J.A.1
Chittick, G.E.2
Ravitch, J.R.3
Polk, R.E.4
Kerkering, T.M.5
Stein, D.S.6
-
17
-
-
0032135991
-
Neurological efficacy of stavudine, zidovudine, and lamivudine
-
Gisslén M, Svennerholm B, Fuchs D, Hagberg L. Neurological efficacy of stavudine, zidovudine, and lamivudine. Lancet 1998; 352: 402-3.
-
(1998)
Lancet
, vol.352
, pp. 402-403
-
-
Gisslén, M.1
Svennerholm, B.2
Fuchs, D.3
Hagberg, L.4
-
18
-
-
0024376631
-
Declining incidence of AIDS dementia complex after introduction of zidovudine treatment
-
Portegies P, de Gans J, Lange JM, Derix MM, Speelman H, Bakker M, et al. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. Br Med J 1989; 299: 819-21.
-
(1989)
Br. Med. J.
, vol.299
, pp. 819-821
-
-
Portegies, P.1
de Gans, J.2
Lange, J.M.3
Derix, M.M.4
Speelman, H.5
Bakker, M.6
-
19
-
-
0031034408
-
The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine
-
Gisslén M, Norkrans G, Svennerholm B, Hagberg L. The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine. J Infect Dis 1997; 175: 434-7.
-
(1997)
J. Infect. Dis.
, vol.175
, pp. 434-437
-
-
Gisslén, M.1
Norkrans, G.2
Svennerholm, B.3
Hagberg, L.4
-
20
-
-
0032875534
-
Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1 infected patients receiving combination therapy
-
Tashima KT, Caliendo AM, Ahmad M, Gormley JM, Fiske WD, Brennan JM, Flanigan TP. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1 infected patients receiving combination therapy. J Infect Dis 1999; 180: 862-4.
-
(1999)
J. Infect. Dis.
, vol.180
, pp. 862-864
-
-
Tashima, K.T.1
Caliendo, A.M.2
Ahmad, M.3
Gormley, J.M.4
Fiske, W.D.5
Brennan, J.M.6
Flanigan, T.P.7
-
21
-
-
0006848674
-
Estimation of nevirapine exposure within the cerebrospinal fluid using CSF: Plasma area under the curve ratios
-
Sixth Conference on Retroviruses and Oppurtunistic Infections. Chicago, IL, January-February [Abstract no. 406]
-
Kearney B, Price R, Sheiner L. Estimation of nevirapine exposure within the cerebrospinal fluid using CSF:plasma area under the curve ratios. Sixth Conference on Retroviruses and Oppurtunistic Infections. Chicago, IL, January-February 1999 [Abstract no. 406].
-
(1999)
-
-
Kearney, B.1
Price, R.2
Sheiner, L.3
-
22
-
-
0033936554
-
Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir
-
van Praag RM, Weverling GJ, Portegies P, Jurriaans S, Zhou XJ, Turner-Foisy ML, et al. Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir. Aids 2000; 14: 1187-94.
-
(2000)
Aids
, vol.14
, pp. 1187-1194
-
-
van Praag, R.M.1
Weverling, G.J.2
Portegies, P.3
Jurriaans, S.4
Zhou, X.J.5
Turner-Foisy, M.L.6
-
23
-
-
0032839781
-
Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir
-
Kravcik S, Gallicano K, Roth V, Cassol S, Hawley-Foss N, Badley A, Cameron DW. Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir. J Acquir Immune Defic Syndr 1999; 21: 371-5.
-
(1999)
J. Acquir. Immune Defic. Syndr.
, vol.21
, pp. 371-375
-
-
Kravcik, S.1
Gallicano, K.2
Roth, V.3
Cassol, S.4
Hawley-Foss, N.5
Badley, A.6
Cameron, D.W.7
-
24
-
-
0032948171
-
Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1 infected patients with and without AIDS dementia complex
-
Aweeka F, Jayewardene A, Staprans S, Bellibas SE, Kearney B, Lizak P, et al. Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1 infected patients with and without AIDS dementia complex. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20: 39-43.
-
(1999)
J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.
, vol.20
, pp. 39-43
-
-
Aweeka, F.1
Jayewardene, A.2
Staprans, S.3
Bellibas, S.E.4
Kearney, B.5
Lizak, P.6
-
25
-
-
0036184628
-
Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: Clinical correlations
-
Lafeuillade A, Solas C, Halfon P, Chadapaud S, Hittinger G, Lacarelle B. Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations. HIV Clin Trials 2002; 3: 27-35.
-
(2002)
HIV Clin. Trials
, vol.3
, pp. 27-35
-
-
Lafeuillade, A.1
Solas, C.2
Halfon, P.3
Chadapaud, S.4
Hittinger, G.5
Lacarelle, B.6
-
26
-
-
12244294518
-
Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients
-
Solas C, Lafeuillade A, Halfon P, Chadapaud S, Hittinger G, Lacarelle B. Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 2003; 47: 238-43.
-
(2003)
Antimicrob. Agents Chemother.
, vol.47
, pp. 238-243
-
-
Solas, C.1
Lafeuillade, A.2
Halfon, P.3
Chadapaud, S.4
Hittinger, G.5
Lacarelle, B.6
-
27
-
-
0033853163
-
Cerebrospinal fluid and plasma viral load in HIV-1 infected patients with various anti-retroviral treatment regimens
-
Gisslén M, Svennerholm B, Norkrans G, Franzen C, Sall C, Svensson R, et al. Cerebrospinal fluid and plasma viral load in HIV-1 infected patients with various anti-retroviral treatment regimens. Scand J Infect Dis 2000; 32: 365-9.
-
(2000)
Scand. J. Infect. Dis.
, vol.32
, pp. 365-369
-
-
Gisslén, M.1
Svennerholm, B.2
Norkrans, G.3
Franzen, C.4
Sall, C.5
Svensson, R.6
-
28
-
-
0033178428
-
Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection
-
Gisslén M, Fuchs D, Svennerholm B, Hagberg L. Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J Acquir Immune Defic Syndr 1999; 21: 271-6.
-
(1999)
J. Acquir. Immune Defic. Syndr.
, vol.21
, pp. 271-276
-
-
Gisslén, M.1
Fuchs, D.2
Svennerholm, B.3
Hagberg, L.4
-
29
-
-
0034701034
-
Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources
-
Ellis RJ, Gamst AC, Capparelli E, Spector SA, Hsia K, Wolfson T, et al. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 2000; 54: 927-36.
-
(2000)
Neurology
, vol.54
, pp. 927-936
-
-
Ellis, R.J.1
Gamst, A.C.2
Capparelli, E.3
Spector, S.A.4
Hsia, K.5
Wolfson, T.6
-
30
-
-
0021264311
-
Immune response-associated production of neopterin release from macrophages primarily under control of interferon-gamma
-
Huber C, Batchelor R, Fuchs D, Hause A, Lang A, Niederwieser D. Immune response-associated production of neopterin release from macrophages primarily under control of interferon-gamma. J Exp Med 1984; 160: 310-6.
-
(1984)
J. Exp. Med.
, vol.160
, pp. 310-316
-
-
Huber, C.1
Batchelor, R.2
Fuchs, D.3
Hause, A.4
Lang, A.5
Niederwieser, D.6
-
31
-
-
0037045074
-
Continuing intrathecal immunoactivation despite 2 y of effective antiretroviral therapy against HIV-1 infection
-
Abdulle S, Hagberg L, Svennerholm B, Fuchs D, Gisslén M. Continuing intrathecal immunoactivation despite 2 y of effective antiretroviral therapy against HIV-1 infection. Aids 2002; 16: 2145-9.
-
(2002)
Aids
, vol.16
, pp. 2145-2149
-
-
Abdulle, S.1
Hagberg, L.2
Svennerholm, B.3
Fuchs, D.4
Gisslén, M.5
|